Clinical Trials Directory

Trials / Completed

CompletedNCT04399694

Identification and Characterization of Novel Non-Coding Variants That Contribute to Genetic Disorders

Identification and Characterization of Novel Coding, Splicing and Non-Coding Variants That Contribute to Genetic Disorders

Status
Completed
Phase
Study type
Observational
Enrollment
56 (actual)
Sponsor
Duke University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The goal of this study is to identify and characterize novel non-coding and splicing variants that may contribute to genetic disorders. We will particularly focus on patients with a diagnosed genetic disorder that has inconclusive genetic findings.

Detailed description

To perform this study, we will use patient DNA and RNA that is isolated from blood samples. DNA will be sequenced (targeted capture and/or whole genome DNA sequencing (WGS)) to identify any non-coding single nucleotide variants (SNVs), smaller insertions/deletions (indels), or larger structural variants (SVs). RNA will be sequenced (RNA-seq) to identify genes that are expressed in a differential and/or allele-specific manner, which may indicate a functional non-coding or splicing variant. We will test the function of non-coding variants using high-throughput reporter assays and CRISPR based methodologies.

Conditions

Timeline

Start date
2020-03-03
Primary completion
2024-04-11
Completion
2024-04-11
First posted
2020-05-22
Last updated
2026-01-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04399694. Inclusion in this directory is not an endorsement.

Identification and Characterization of Novel Non-Coding Variants That Contribute to Genetic Disorders (NCT04399694) · Clinical Trials Directory